Early HR+

Early HR+

Early-Stage HR+ Breast Cancer treatment update on managing CDK4/6 inhibitor sequencing with expert physicians at OncUpdates.

Early HR+

01/09/2026

Ep. 4: Early-Stage HR-Positive Breast Cancer: Managing CDK4/6 Inhibitor Sequencing

Sara Hurvitz, MD, FACPSherry Shen, MDEleonora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD

Liver toxicity research with expert doctors discussing risk stratification and personalized adjuvant therapy in early-stage HR+ breast cancer treatment.

Early HR+

01/07/2026

Ep. 3: Liver Toxicity, Risk Stratification, and Personalized Adjuvant Therapy in Early-Stage HR-Positive Disease

Sara Hurvitz, MD, FACPSherry Shen, MDEleonora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD

1. Expert panel on practical guidance for Ribociclib and Abemaciclib in adjuvant cancer therapy, featuring leading oncologists discussing advanced treatment strategies.

Early HR+

01/05/2026

Ep. 2: Practical Guidance for Ribociclib and Abemaciclib in the Adjuvant Setting

Sara Hurvitz, MD, FACPSherry Shen, MDEleonora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD

Adjuvant Ribociclib in early-stage HR+ breast cancer clinical insights featuring expert doctors and research leaders.

Early HR+

01/03/2026

Ep. 1: Adjuvant Ribociclib in Early-Stage HR-Positive Breast Cancer: Clinical Insights

Sara Hurvitz, MD, FACPSherry Shen, MDEleonora Teplinsky, MDRahul Gosain, MD, MBARohit Gosain, MD

Adjuvant CDK4/6 therapy in early HR+ breast cancer, featuring Dr. Eleonora Teplinsky, Dr. Sherry Shen, Dr. Rahul Gosain, Dr. Sara Hurwitz, and Dr. Rohit Gosain, with clinical insights and expertise.

Early HR+

12/20/2025

Adjuvant Ribociclib and Abemaciclib in Early HR+ Breast Cancer (Full Video)

Eleonora Teplinsky, MDSara Hurvitz, MD, FACPSherry Shen, MDRahul Gosain, MD, MBARohit Gosain, MD